Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.6 USD | -4.06% | -1.89% | -23.08% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 329K | Capitalization | 102M |
---|---|---|---|---|---|
Net income 2024 * | -96M | Net income 2025 * | -123M | EV / Sales 2024 * | - |
Net cash position 2024 * | 43.16M | Net cash position 2025 * | 178M | EV / Sales 2025 * | -232 x |
P/E ratio 2024 * |
-1.25
x | P/E ratio 2025 * |
-1.17
x | Employees | 69 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.75% |
Latest transcript on Vigil Neuroscience, Inc.
1 day | -4.06% | ||
1 week | -1.89% | ||
Current month | -23.75% | ||
1 month | -20.97% | ||
3 months | -8.77% | ||
6 months | -67.25% | ||
Current year | -23.08% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 20-06-30 | |
Director of Finance/CFO | 50 | 20-06-30 | |
Kelly Neelon
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 20-06-30 | |
Mary Thistle
BRD | Director/Board Member | 64 | 22-04-17 |
Cheryl Blanchard
BRD | Director/Board Member | 59 | 20-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.43% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 2.6 | -4.06% | 68,363 |
24-04-26 | 2.71 | +5.04% | 46,561 |
24-04-25 | 2.58 | -6.86% | 66,727 |
24-04-24 | 2.77 | +4.53% | 63,451 |
24-04-23 | 2.65 | -6.69% | 67,149 |
Delayed Quote Nasdaq, April 29, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.08% | 102M | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- VIGL Stock